Company: ARVN
Filing Date: 2025-04-29
Form Type: DEF 14A
Source: 0001655759-25-000075
Chunk: 65

Company: ARVINAS, INC.
Filing Date: 2025-04-29
Form: DEF 14A
Chunk 65
---
 may be in the form of cash, equity award, or a combination of cash and equity. Dr. Houston is eligible for an annual bonus of up to 60% of his base salary. Each of Dr. Berkowitz, Dr. Cacace, Mr. Saik and Dr. Taylor is eligible for an annual bonus of up to 45% of his or her base salary. Dr. Teel was entitled to an annual bonus of up to 45% of his base salary effective as of April 21, 2024, when he was appointed as our Chief Business Officer. Mr. Ca ssidy was eligible for an annual bonus of up to 45% of his base salary prior to his departure from the company in February 2024.

<div align='center'>48</div>

Potential Payments upon Termination or Change in Control

T he employee arrangements and the employment of each of our current named executive officers may be (or could have been, in the case of Mr. Cassidy) terminated as follows: (1) upon the death or “disability” (as disability is defined in the applicable employment arrangement) of such named executive officer; (2) at our election, with or without “cause” (as cause is defined in the applicable employment arrangement); and (3) at such named executive officer’s election, with or without “good reason” (as good reason is defined in the applicable employment arrangement).

In the event of the termination of Dr. Houston’s employment by us without cause, or by him for good reason, prior to or more than twelve months following a “change in control” (as change in control is defined in his employment agreement), Dr. Houston is entitled to his base salary that has accrued and to which he is entitled as of the termination date and accrued but unused paid time off through and including the termination date and other accrued benefits, which we refer to collectively as, the accrued obligations. In addition, subject to his execution and nonrevocation of a release of claims in our favor and his continued compliance with his proprietary rights, non-disclosure, developments, non-competition and non-solicitation agreement and any similar agreement with us, he is entitled to (1) continued payment of his base salary, in accordance with our regular payroll procedures, for a period of 12 months and (2) provided he is eligible for and timely elects to continue receiving group medical insurance under COBRA and the payments would not result in the violation of nondiscrimination requirements of applicable law,